|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
153,922,000 |
Market
Cap: |
6.15(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$36.9 - $39.95 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile IVERIC bio is biopharmaceutical company focused on the discovery and development of treatments for retinal diseases with unmet medical needs. Co.'s clinical stage product candidate, Zimura® (avacincaptad pegol), a complement C5 inhibitor. Co. is targeting the following diseases with Zimura: Geographic Atrophy, intermediate age-related macular degeneration, and autosomal recessive Stargardt disease. In addition to Zimura, Co. is developing its preclinical product candidate IC-500, a high temperature requirement A serine peptidase 1 protein inhibitor, for GA and potentially other age-related retinal diseases.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
40,000 |
561,286 |
Total Sell Value |
$0 |
$0 |
$1,546,400 |
$15,378,126 |
Total People Sold |
0 |
0 |
1 |
5 |
Total Sell Transactions |
0 |
0 |
2 |
30 |
End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Patel Samir Chandrakant |
President |
|
2016-01-29 |
4 |
AS |
$53.33 |
$1,071,740 |
D/D |
(20,000) |
260,911 |
|
- |
|
Guyer David R |
Chief Executive Officer |
|
2016-01-28 |
4 |
AS |
$53.35 |
$997,375 |
D/D |
(18,598) |
32,391 |
|
- |
|
Guyer David R |
Chief Executive Officer |
|
2016-01-28 |
4 |
OE |
$10.03 |
$186,538 |
D/D |
18,598 |
50,989 |
|
- |
|
Galakatos Nicholas |
Director |
|
2016-01-11 |
4 |
AS |
$65.33 |
$65,390 |
I/I |
(1,000) |
3,945 |
|
- |
|
Galakatos Nicholas |
Director |
|
2016-01-11 |
4 |
AS |
$65.45 |
$131,781 |
D/D |
(2,000) |
5,684 |
|
- |
|
Wood Barbara A |
SVP,General Counsel,Secretary |
|
2016-01-04 |
4 |
AS |
$76.37 |
$76,370 |
D/D |
(1,000) |
746 |
|
- |
|
Wood Barbara A |
SVP,General Counsel,Secretary |
|
2016-01-04 |
4 |
OE |
$24.49 |
$24,490 |
D/D |
1,000 |
1,746 |
|
- |
|
Guyer David R |
Chief Executive Officer |
|
2016-01-04 |
4 |
S |
$71.15 |
$237,140 |
D/D |
(3,269) |
32,391 |
|
- |
|
Wood Barbara A |
SVP,General Counsel,Secretary |
|
2016-01-04 |
4 |
S |
$71.15 |
$45,629 |
D/D |
(629) |
746 |
|
- |
|
Atieh Michael G |
EVP, CFO, & CBO, Treasurer |
|
2016-01-04 |
4 |
S |
$71.15 |
$9,430 |
D/D |
(130) |
295 |
|
- |
|
Patel Samir Chandrakant |
President |
|
2016-01-04 |
4 |
S |
$71.15 |
$186,361 |
D/D |
(2,569) |
280,911 |
|
- |
|
Guyer David R |
Chief Executive Officer |
|
2016-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,750 |
35,660 |
|
- |
|
Wood Barbara A |
SVP,General Counsel,Secretary |
|
2016-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,375 |
1,375 |
|
- |
|
Atieh Michael G |
EVP, CFO, & CBO, Treasurer |
|
2016-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
425 |
425 |
|
- |
|
Patel Samir Chandrakant |
President |
|
2016-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,875 |
283,480 |
|
- |
|
Sblendorio Glenn |
Director |
|
2015-12-30 |
4 |
AS |
$80.00 |
$160,000 |
D/D |
(2,000) |
0 |
|
- |
|
Sblendorio Glenn |
Director |
|
2015-12-30 |
4 |
OE |
$13.22 |
$26,432 |
D/D |
2,000 |
2,000 |
|
- |
|
Guyer David R |
Chief Executive Officer |
|
2015-12-30 |
4 |
AS |
$78.53 |
$1,464,666 |
D/D |
(18,582) |
29,910 |
|
- |
|
Guyer David R |
Chief Executive Officer |
|
2015-12-30 |
4 |
OE |
$10.03 |
$186,377 |
D/D |
18,582 |
48,492 |
|
- |
|
Patel Samir Chandrakant |
President |
|
2015-12-29 |
4 |
AS |
$77.00 |
$91,761 |
D/D |
(1,184) |
278,605 |
|
- |
|
Patel Samir Chandrakant |
President |
|
2015-12-29 |
4 |
OE |
$13.22 |
$15,648 |
D/D |
1,184 |
279,789 |
|
- |
|
Patel Samir Chandrakant |
President |
|
2015-12-24 |
4 |
AS |
$76.42 |
$2,007,102 |
D/D |
(26,036) |
278,605 |
|
- |
|
Patel Samir Chandrakant |
President |
|
2015-12-24 |
4 |
OE |
$1.65 |
$543,716 |
D/D |
26,036 |
304,641 |
|
- |
|
Galakatos Nicholas |
Director |
|
2015-12-10 |
4 |
AS |
$63.91 |
$64,438 |
I/I |
(1,000) |
4,945 |
|
- |
|
Galakatos Nicholas |
Director |
|
2015-12-10 |
4 |
AS |
$63.90 |
$128,871 |
D/D |
(2,000) |
7,684 |
|
- |
|
468 Records found
|
|
Page 13 of 19 |
|
|